South Korea's expert panel says J&J Covid-19 vaccine safe, effective for approval
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[SEOUL] A panel of South Korean advisers recommended a coronavirus vaccine from Johnson & Johnson was safe and effective, the food and drug safety ministry said on Monday, moving the single-dose shot a step closer to receiving regulatory approval.
When granted a greenlight, the J&J vaccine will be the third Covid-19 vaccine authorised in South Korea, following ones from AstraZeneca and Pfizer/BioNTech, both of which require two doses.
South Korea has an agreement to get 6 million doses of the J&J vaccine and has said it will be ready for inoculation from the second quarter.
The final authorisation of the vaccine will be decided after two more expert committees hold meetings.
The country has so far administered 793,966 first doses of vaccines among medical workers and high-risk groups since the beginning of its vaccination campaign in February.
REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
S-E Asia tourism takes hit from Middle East crisis, but intra-regional travel could spell hope
Higher costs, lower returns: Why are Singaporeans still betting on real estate?
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
